Eledon Pharmaceuticals, Inc. — Cash Flow Charts
15 quarters of history · ending 2017-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+90.9% +$9M
$-882K
Free Cash Flow↑+91.0% +$9M
$-882K
Investing Cash Flow↑+25541.2% +$4M
$4M
Financing Cash Flow↑+981.1% +$363K
$400K
Capex↓-100.0% -$157K
$0
Stock-Based Comp↑+483.2% +$488K
$589K
D&A↓-92.5% -$49K
$4K
SBC Allocated Expense↓-89.6% -$916K
$106K
SBC Unrecognized Cost↑+187.4% +$4M
$6M